UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018459
Receipt number R000021378
Scientific Title Japan Diabetes Mellitus Effective Network System Study
Date of disclosure of the study information 2015/07/31
Last modified on 2015/07/30 11:19:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Japan Diabetes Mellitus Effective Network System Study

Acronym

J-DEFENS Study

Scientific Title

Japan Diabetes Mellitus Effective Network System Study

Scientific Title:Acronym

J-DEFENS Study

Region

Japan


Condition

Condition

Type 2 Diabetes mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This purpose of this study is as follows:
1) Expansion and standardization of medical cooperation on the research of diabetes.
2) Clarification of the preventive effect of diabetic complications and the economic effect by the medical cooperation on the research of diabetes.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1)Fasting plasma glucose
2)HbA1c

Key secondary outcomes

1)Severity of diabetic complications
2)The frequency of the examination for diabetic complications
3)The onset and progression of diabetic complications


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Type 2 diabetes.
2) Lower age limit: 20 years old
3) Gender: male and female.
4) Outpatients and/or inpatients receiving treatment for lifestyle disease at a hospital.
5) Patients who have provided written informed consent.

Key exclusion criteria

1) Secondary obesity associated with endocrine disorders.
2) Severe liver dysfunction and liver cirrhosis.
3) Severe renal dysfunction (serum creatinine >= 2.0mg/dl).
4) Patients who are pregnant.
5) Subjects judged by the investigator/project lead to be ineligible for other reasons.

Target sample size

1500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Noriko Satoh-Asahara

Organization

National Hospital Organization, Kyoto Medical Center

Division name

Division of Diabetic Research, Clinical Research Institute

Zip code


Address

1-1 Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto

TEL

075-641-9161

Email

nsato@kyotolan.hosp.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Noriko Satoh-Asahara

Organization

National Hospital Organization, Kyoto Medical Center

Division name

Division of Diabetic Research, Clinical Research Institute

Zip code


Address

1-1 Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto

TEL

075-641-9161

Homepage URL


Email

nsatoh@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

National Hospital Organization, Kyoto Medical Center

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

15Aek0210029h0002

Org. issuing International ID_1

Japan Agency for Medical Research and Development

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都医療センター(京都)、自治医科大学(栃木県)、東京医科歯科大学(東京)、大阪赤十字病院(大阪)、市立岸和田市民病院(大阪)、嶋田病院(福岡県)


Other administrative information

Date of disclosure of the study information

2015 Year 07 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2015 Year 07 Month 26 Day

Date of IRB


Anticipated trial start date

2015 Year 08 Month 01 Day

Last follow-up date

2017 Year 09 Month 30 Day

Date of closure to data entry

2017 Year 10 Month 31 Day

Date trial data considered complete

2017 Year 11 Month 30 Day

Date analysis concluded

2018 Year 03 Month 31 Day


Other

Other related information

prospective cohort study


Management information

Registered date

2015 Year 07 Month 28 Day

Last modified on

2015 Year 07 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021378


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name